Abstract RF2-01: Prognostic Markers in Residual Tumors after neoadjuvant chemotherapy (NACT) for Early Triple-negative Breast Cancer (TNBC) - a Pooled Analysis from nine Neoadjuvant GBG/AGO-B Trials
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: J. Holtschmidt, A. Schneeweiss, N. Frickel, N. Filmann, M. Untch, A. Hartkopf, V. Müller, C. Solbach, M. van Mackelenbergh, J. Blohmer, K. Lübbe, T. Karn, F. Holms, P. A. Fasching, P. Jank, M. Darsow, F. Marmé, M. Braun, E. Stickeler, R. Weide, T. Fehm, C. Schem, A. Eidmann, B. Felder, S. Loibl, C. Denkert
Institutions: German Breast Group, German Cancer Research Center, University Hospital Heidelberg, National Center for Tumor Diseases, Philipps University of Marburg, Helios Kliniken, Helios Hospital Berlin-Buch, Universitätsklinikum Tübingen, University Medical Center Hamburg-Eppendorf, Goethe University Frankfurt, University Hospital Schleswig-Holstein, Charité - Universitätsmedizin Berlin, Diakovere, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, Luisenkrankenhaus, Heidelberg University, University Medical Centre Mannheim, Universitätsklinikum Aachen, RWTH Aachen University, Düsseldorf University Hospital, Mammazentrum Hamburg, Krankenhaus Jerusalem, Universitätsklinikum Gießen und Marburg
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129550922